Antimicrobial Resistance Surveillance Market Size - By Solution (Diagnostic Kits, Systems, & Software), Application (Public Health Surveillance, Laboratory Surveillance, Clinical Diagnostics), End-use (Hospitals, Clinics) & Forecast, 2024 - 2032

Antimicrobial Resistance Surveillance Market size is projected to expand at 5.8% CAGR from 2024 to 2032 driven by the collaborative efforts among healthcare organizations, research institutions, and government bodies.

Increasing partnerships are fostering innovations in surveillance technologies, enabling the development of advanced tools for detecting and tracking resistant pathogens. For instance, in June 2023, several researchers at the Public Health Agency of Canada's National Microbiology Laboratory (NML) investigated the prevalence of antimicrobial resistance in Canada. Recognizing the need for a network that could capture data from across the nation, the NML created the Antimicrobial Resistance Network, or AMRNet, a lab-based monitoring system to collect data from bacterial and fungal samples tested for AMR in clinical and veterinary labs. Such collaborative initiatives pool resources, expertise, and data to enhance surveillance capabilities, leading to more effective strategies for antimicrobial resistance control, thereby augmenting the market outlook.

The overall industry is segmented into solution, application, end-use, and region.

In terms of solution, the antimicrobial resistance surveillance market from the diagnostic software segment is anticipated to witness 6.3% growth rate from 2024-2032. Advanced software solutions for antimicrobial resistance surveillance offer real-time monitoring, data analysis, and trend identification, aiding healthcare facilities in effective decision-making and infection control measures. They also provide rapid identification of resistant pathogens for enabling timely interventions and treatment strategies. Moreover, the integration of AI and ML algorithms enhances the accuracy and efficiency of surveillance systems, further adding to the segment growth.

Based on application, the antimicrobial resistance surveillance industry from the public health surveillance segment generated considerable revenue in 2023 and is estimated to depict a 6.1% CAGR between 2024 and 2032. Public health agencies worldwide rely on advanced surveillance systems to monitor and track the spread of antimicrobial resistance. Enhanced surveillance enables timely interventions, policy developments, and targeted interventions to combat antimicrobial resistance on a broader scale. With the increasing focus on preventing the spread of resistant pathogens and improving patient outcomes, the demand for robust public health surveillance solutions will rise.

Regionally, the Asia Pacific antimicrobial resistance surveillance industry is set to exhibit 6.3% CAGR during 2024-2032. The large and diverse population coupled with the rising healthcare expenditure are fueling the demand for effective surveillance solutions in the region. There are several government initiatives aimed at controlling infectious diseases and improving healthcare infrastructure. Additionally, the increasing prevalence of antimicrobial-resistant pathogens is driving the adoption of advanced surveillance technologies, thereby augmenting the regional industry outlook.